Keyphrases
Semicarbazide-sensitive Amine Oxidase
100%
Vascular Adhesion protein-1 (VAP-1)
90%
Alzheimer's Disease
46%
Oxidase Activity
36%
Cerebral Ischemia
27%
Cerebral Amyloid Angiopathy
23%
Transgenic Mouse Model
21%
Oxygen-glucose Deprivation
20%
Vascular Amyloid
19%
Neurodegeneration
18%
Cerebrovascular Disease
18%
AMPA Receptor (AMPAR)
17%
Long-term Depression
15%
Stroke Disease
13%
Alzheimer's Disease Model
13%
Vascular Cells
13%
Retina
13%
GluA1
13%
Amyloid-β Peptide
12%
Monoamine Oxidase A (MAO-A)
12%
Mouse Brain
11%
Therapeutic Approaches
11%
Disease-based
11%
Protective Effect
11%
Synaptic Plasticity
11%
Monoamine Oxidase B (MAO-B)
11%
Biological Evaluation
11%
Neuropathology
10%
Protective Behavior
10%
Endothelial Cells
10%
Apoptosis
10%
Therapeutic Effect
10%
Membrane Binding
10%
Neurological Outcome
10%
Amyloid beta
10%
Tissue Plasminogen Activator (t-PA)
9%
Hemorrhagic Stroke
9%
Radiometric Methods
9%
Transepithelial Electrical Resistance
9%
1,2,3-Triazol
9%
AMPA Receptor Endocytosis
9%
AKAP150
9%
Synapse Dysfunction
9%
Stricter Regulation
9%
Immunohistochemical Study
9%
Brain Diseases
9%
Monoaminergic
9%
Monoamine Oxidase B Inhibitors
9%
N-methylation
9%
Executor
9%
Neuroscience
Vascular Adhesion Protein 1
81%
Amine Oxidase (Copper Containing)
75%
Cerebrovascular Accident
60%
Alzheimer's Disease
59%
Brain Ischemia
36%
Blood Plasma
22%
In Vitro
21%
Cerebral Hemorrhage
19%
Cerebral Amyloid Angiopathy
18%
AMPA Receptor
17%
Amyloid Protein
15%
Diabetes Mellitus
14%
Cell Line
12%
Cognitive Disorders
12%
Neurodegeneration
11%
Photoreceptor Cell
11%
Protein Expression
11%
Leukocyte
10%
Amyloidosis
10%
Tissue Plasminogen Activator
9%
Theobromine
9%
Caspase
9%
XIAP
9%
Simvastatin
9%
Cholinergic
9%
Propionic Acid
9%
Vascular Disease
9%
Apolipoprotein A
9%
Gliosis
9%
Retina S Antigen
9%
Cerebrovascular Disease
9%
Sodium Bicarbonate
9%
Monoamine
9%
Synapse
9%
B Cell
9%
Lactoferrin
9%
Endocytosis
9%
Cerebral Cortex
9%
Brain Disease
9%
Oligomer
9%
Notch
9%
Receptor
9%
Polyunsaturated Fatty Acid
9%
Enzyme Activity
7%
Mucin 1
6%
Long-Term Depression
6%
Monoamine Oxidase
6%
Parkinson's Disease
6%
Protein S
6%
Small Cytoplasmic RNA
5%
Medicine and Dentistry
Amine Oxidase (Copper-Containing)
57%
Vascular Adhesion Protein-1
44%
Apoplexy
42%
Alzheimer's Disease
29%
Brain Ischemia
20%
Cognitive Defect
12%
Diseases
11%
Vascular Adhesion Protein 1
11%
Endothelial Cell
10%
Tissue Plasminogen Activator
9%
Cerebral Hemorrhage
9%
Vascular Smooth Muscle Cell
9%
Programmed Cell Death
9%
Alpha Tocopherol
9%
Blood Vessel Tone
9%
Cholinergic System
9%
Vanilloid Receptor 2
9%
Amyloid Beta
9%
Monoamine
9%
Vascular Cell Line
9%
Cerebrovascular Disease
9%
In Vitro
9%
Vascular Disease
9%
Polyphenol
9%
B Lymphocyte
9%
Theobromine
9%
Catecholaminergic System
9%
Brain Disease
9%
Monoaminergic System
9%
Polyunsaturated Fatty Acid
9%
Antioxidant
6%
Enzyme Activity
6%
Side Effect
6%
Medicine
6%
Parkinson's Disease
6%
Methylamine
6%
Leukocyte
5%
Pathophysiology
5%
Amine Oxidase (Flavin Containing)
5%
Amyloid Protein
5%
